![DNA Explainer: Difference between Delta and Delta Plus variants - Symptoms, treatment, who's at risk DNA Explainer: Difference between Delta and Delta Plus variants - Symptoms, treatment, who's at risk](https://cdn.dnaindia.com/sites/default/files/styles/full/public/2021/06/28/982251-coronavirus-delta-plus-variant.jpg)
DNA Explainer: Difference between Delta and Delta Plus variants - Symptoms, treatment, who's at risk
![COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1619703711/GettyImages-1293456793.jpg/GettyImages-1293456793.jpg?VersionId=WB8tj9FiBVgpCnJxtaqj0TT3Gnf4tWIM)
COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma
![Baricitinib plus remdesivir shows promise for treating COVID-19 | National Institutes of Health (NIH) Baricitinib plus remdesivir shows promise for treating COVID-19 | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/styles/featured_media_breakpoint-medium/public/news-events/news-releases/2020/20201211-covid.jpg?itok=GwUKbKQV×tamp=1607709840)
Baricitinib plus remdesivir shows promise for treating COVID-19 | National Institutes of Health (NIH)
Coronavirus Delta Plus Variant Prevention: What you can do to protect yourself from Delta Plus variant, as per experts
![Vaccination Plus Breakthrough Infection Might Give 'Super Immunity' Against New Variants - Consumer Health News | HealthDay Vaccination Plus Breakthrough Infection Might Give 'Super Immunity' Against New Variants - Consumer Health News | HealthDay](https://consumer.healthday.com/media-library/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yNjQyNDIzOC9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTcwODQ5MzY4MH0.P1Xn05CSuqRkd0WeCC3I1yaQQLb_560fZW7jXKKxlvo/image.jpg?width=1245&quality=85&coordinates=0%2C91%2C0%2C92&height=700)
Vaccination Plus Breakthrough Infection Might Give 'Super Immunity' Against New Variants - Consumer Health News | HealthDay
![NIH clinical trial testing antiviral remdesivir plus anti-inflammatory drug baricitinib for COVID-19 begins | National Institutes of Health (NIH) NIH clinical trial testing antiviral remdesivir plus anti-inflammatory drug baricitinib for COVID-19 begins | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/news-events/news-releases/2020/20200508-covid-19.jpg)